Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 284

Similar articles for PubMed (Select 24889042)

1.

Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.

Yoshida H, Yamamoto N, Taniguchi H, Oda I, Katai H, Kushima R, Tsuda H.

Virchows Arch. 2014 Aug;465(2):145-54. doi: 10.1007/s00428-014-1597-3. Epub 2014 Jun 3.

PMID:
24889042
2.
3.

Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.

He C, Bian XY, Ni XZ, Shen DP, Shen YY, Liu H, Shen ZY, Liu Q.

World J Gastroenterol. 2013;19(14):2171-8. doi: 10.3748/wjg.v19.i14.2171.

4.

Dual-colour HER2/chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samples.

Yan B, Yau EX, Choo SN, Ong CW, Yong KJ, Pang B, Salto-Tellez M.

J Clin Pathol. 2011 Oct;64(10):880-3. doi: 10.1136/jclinpath-2011-200009. Epub 2011 Jul 14.

PMID:
21757431
5.

HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens.

Tsuda H, Kurosumi M, Umemura S, Yamamoto S, Kobayashi T, Osamura RY.

BMC Cancer. 2010 Oct 7;10:534. doi: 10.1186/1471-2407-10-534.

6.

Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma.

Kimura M, Tsuda H, Morita D, Shinto E, Tanimoto T, Ichikura T, Mochizuki H, Matsubara O.

Jpn J Clin Oncol. 2005 Jun;35(6):324-31. Epub 2005 May 31.

7.

Human epidermal growth factor receptor 2 testing in gastroesophageal cancer: correlation between immunohistochemistry and fluorescence in situ hybridization.

Tafe LJ, Janjigian YY, Zaidinski M, Hedvat CV, Hameed MR, Tang LH, Hicks JB, Shah MA, Barbashina V.

Arch Pathol Lab Med. 2011 Nov;135(11):1460-5. doi: 10.5858/arpa.2010-0541-OA.

PMID:
22032573
8.

[Analysis of HER2 gene status in breast cancer with HER2 protein overexpression].

Zeng X, Liang ZY, Wu SF, Zhou WX, Gao J, Liu TH.

Zhonghua Bing Li Xue Za Zhi. 2006 Oct;35(10):584-8. Chinese.

PMID:
17134563
9.

Intratumoral heterogeneity determines discordant results of diagnostic tests for human epidermal growth factor receptor (HER) 2 in gastric cancer specimens.

Yang J, Luo H, Li Y, Li J, Cai Z, Su X, Dai D, Du W, Chen T, Chen M.

Cell Biochem Biophys. 2012 Jan;62(1):221-8. doi: 10.1007/s12013-011-9286-1.

PMID:
21927816
10.

Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use?

Park YS, Hwang HS, Park HJ, Ryu MH, Chang HM, Yook JH, Kim BS, Jang SJ, Kang YK.

Hum Pathol. 2012 Mar;43(3):413-22. doi: 10.1016/j.humpath.2011.05.019. Epub 2011 Aug 19.

PMID:
21855114
11.

Matched biopsy and resection specimens of gastric and gastroesophageal adenocarcinoma show high concordance in HER2 status.

Wang T, Hsieh ET, Henry P, Hanna W, Streutker CJ, Grin A.

Hum Pathol. 2014 May;45(5):970-5. doi: 10.1016/j.humpath.2013.12.010. Epub 2014 Jan 8.

PMID:
24656529
12.

A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.

Cho J, Jeong J, Sung J, Sung CO, Kim KM, Park CK, Choi MG, Sohn TS, Bae JM, Kim S.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S477-84. doi: 10.1245/s10434-012-2818-0. Epub 2012 Dec 30.

PMID:
23274580
13.

HER2 in resected gastric cancer: Is there prognostic value?

Fisher SB, Fisher KE, Squires MH 3rd, Patel SH, Kooby DA, El-Rayes BF, Cardona K, Russell MC, Staley CA 3rd, Farris AB 3rd, Maithel SK.

J Surg Oncol. 2014 Feb;109(2):61-6. doi: 10.1002/jso.23456. Epub 2013 Oct 10.

PMID:
24122802
14.
15.

Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.

Sornmayura P, Rerkamnuaychoke B, Jinawath A, Euanorasetr C.

J Med Assoc Thai. 2012 Jan;95(1):88-95.

PMID:
22379747
16.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Liang Z, Zeng X, Gao J, Wu S, Wang P, Shi X, Zhang J, Liu T.

BMC Cancer. 2008 Dec 6;8:363. doi: 10.1186/1471-2407-8-363.

17.

Are biopsy specimens predictive of HER2 status in gastric cancer patients?

Pirrelli M, Caruso ML, Di Maggio M, Armentano R, Valentini AM.

Dig Dis Sci. 2013 Feb;58(2):397-404. doi: 10.1007/s10620-012-2357-3. Epub 2012 Aug 24.

PMID:
22918687
18.

HER2 status in lung adenocarcinoma: a comparison of immunohistochemistry, fluorescence in situ hybridization (FISH), dual-ISH, and gene mutations.

Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Uehara T, Fujimoto M, Tsuruyama T, Date H, Haga H.

Lung Cancer. 2014 Sep;85(3):373-8. doi: 10.1016/j.lungcan.2014.06.007. Epub 2014 Jul 7.

PMID:
25047676
19.

HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH).

Boers JE, Meeuwissen H, Methorst N.

Histopathology. 2011 Feb;58(3):383-94. doi: 10.1111/j.1365-2559.2011.03760.x. Epub 2011 Feb 16.

20.

Assessment of HER2/Neu status by fluorescence in situ hybridization in immunohistochemistry-equivocal cases of invasive ductal carcinoma and aberrant signal patterns: a study at a tertiary cancer center.

Murthy SS, Sandhya DG, Ahmed F, Goud KI, Dayal M, Suseela K, Rajappa SJ.

Indian J Pathol Microbiol. 2011 Jul-Sep;54(3):532-8. doi: 10.4103/0377-4929.85087.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk